<VariationArchive VariationID="2062725" VariationName="NM_001017420.3(ESCO2):c.845_848del (p.Lys282fs)" VariationType="Deletion" Accession="VCV002062725" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2128001" VariationID="2062725">
      <GeneList>
        <Gene Symbol="ESCO2" FullName="establishment of sister chromatid cohesion N-acetyltransferase 2" GeneID="157570" HGNC_ID="HGNC:27230" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="27771974" stop="27819660" display_start="27771974" display_stop="27819660" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="27632057" stop="27662424" display_start="27632057" display_stop="27662424" Strand="+" />
          </Location>
          <OMIM>609353</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001017420.3(ESCO2):c.845_848del (p.Lys282fs)</Name>
      <CanonicalSPDI>NC_000008.11:27777151:AAAGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="27777152" stop="27777155" display_start="27777152" display_stop="27777155" variantLength="4" positionVCF="27777151" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="27634669" stop="27634672" display_start="27634669" display_stop="27634672" variantLength="4" positionVCF="27634668" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K282fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.27634670_27634673del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.27634670_27634673del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.27777153_27777156del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.27777153_27777156del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008117.1" sequenceAccession="NG_008117" sequenceVersion="1" change="g.7613_7616del">
            <Expression>NG_008117.1:g.7613_7616del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017420.3" sequenceAccession="NM_001017420" sequenceVersion="3" change="c.845_848del" MANESelect="true">
            <Expression>NM_001017420.3:c.845_848del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001017420.1" sequenceAccession="NP_001017420" sequenceVersion="1" change="p.Lys282fs">
            <Expression>NP_001017420.1:p.Lys282fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017420.2" sequenceAccession="NM_001017420" sequenceVersion="2" change="c.845_848delAAGA">
            <Expression>NM_001017420.2:c.845_848delAAGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001017420.3(ESCO2):c.845_848del (p.Lys282fs) AND Roberts-SC phocomelia syndrome" Accession="RCV003230759" Version="1">
        <ClassifiedConditionList TraitSetID="445">
          <ClassifiedCondition DB="MedGen" ID="C0392475">Roberts-SC phocomelia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001017420.3(ESCO2):c.845_848del (p.Lys282fs) AND not provided" Accession="RCV002957957" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15821733</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16380922</ID>
        </Citation>
        <DescriptionHistory Dated="2023-06-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="445" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6426" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Roberts-SC phocomelia syndrome</ElementValue>
                <XRef ID="Roberts+syndrome/6342" DB="Genetic Alliance" />
                <XRef ID="MONDO:0100253" DB="MONDO" />
                <XRef ID="48718006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tetraphocomelia-cleft palate syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Roberts syndrome/SC phocomelia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long bone deficiencies associated with cleft lip-palate</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypomelia hypotrichosis facial hemangioma syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SC phocomelia syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RBS</ElementValue>
                <XRef Type="MIM" ID="268300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">ESCO2 spectrum disorder is characterized by mild-to-severe prenatal growth restriction, limb malformations (which can include bilateral symmetric tetraphocomelia or hypomelia caused by mesomelic shortening), hand anomalies (including oligodactyly, thumb aplasia or hypoplasia, and syndactyly), elbow and knee flexion contractures (involving elbows, wrists, knees, ankles, and feet [talipes equinovarus]), and craniofacial abnormalities (which can include bilateral cleft lip and/or cleft palate, micrognathia, widely spaced eyes, exophthalmos, downslanted palpebral fissures, malar flattening, and underdeveloped ala nasi), ear malformation, and corneal opacities. Intellectual disability (ranging from mild to severe) is common. Early mortality is common among severely affected pregnancies and newborns; mildly affected individuals may survive to adulthood.</Attribute>
                <XRef ID="NBK1153" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7387" />
                <XRef ID="7387" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301332</ID>
                <ID Source="BookShelf">NBK1153</ID>
              </Citation>
              <XRef ID="3103" DB="Orphanet" />
              <XRef ID="C0392475" DB="MedGen" />
              <XRef ID="MONDO:0100253" DB="MONDO" />
              <XRef Type="MIM" ID="268300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7343725" SubmissionDate="2023-05-17" DateLastUpdated="2023-06-03" DateCreated="2023-06-03">
        <ClinVarSubmissionID localKey="NM_001017420.2:c.845_848delAAGA|MedGen:C0392475" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003929100" DateUpdated="2023-06-03" DateCreated="2023-06-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: ESCO2 c.845_848delAAGA (p.Lys282ArgfsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in affected individuals (HGMD). The variant allele was found at a frequency of 4.2e-06 in 236404 control chromosomes (gnomAD). To our knowledge, no occurrence of c.845_848delAAGA in individuals affected with Roberts-SC phocomelia syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ESCO2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001017420.2:c.845_848delAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0392475" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13370974</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5962815" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15521990|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003273947" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15821733</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16380922</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This sequence change creates a premature translational stop signal (p.Lys282Argfs*3) in the ESCO2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ESCO2 are known to be pathogenic (PMID: 15821733, 16380922). This variant is present in population databases (rs761404241, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with ESCO2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2062725). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ESCO2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.27634669_27634672del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7343725" TraitType="Disease" MappingType="XRef" MappingValue="C0392475" MappingRef="MedGen">
        <MedGen CUI="C0392475" Name="Roberts-SC phocomelia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5962815" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>